MRI to Help Diagnose and Monitor Angelman Syndrome

MRI to Help Diagnose and Monitor Angelman Syndrome
5
(2)

Reaching a diagnosis of Angelman syndrome is often a difficult and drawn-out process. The symptoms of the disease are similar to several other disorders, and doctors usually reach a diagnosis by a process of elimination. Getting a definitive diagnosis can be a frustrating ordeal for patients and their families.

Historically, doctors thought that patients with the disease had normal magnetic resonance imaging (MRI) findings, but more recent studies have indicated that this may not be the case.

What is MRI?

MRI is a type of imaging technique that is performed at a hospital or clinic. A large machine called an MRI imager collects images of the brain using a large magnet.

The process of taking an MRI can be short, usually five minutes, though sometimes longer scans (up to 20 or 30 minutes) are needed.

For some types of MRI, clinicians use a contrast agent that they inject or infuse into the patient’s body before the MRI begins.

How do patients prepare for an MRI?

No special preparations are needed before undergoing an MRI. The patient will have to wear scrubs or a hospital gown, and remove all jewelry and watches.

Because the imager uses a magnet, some people cannot have the scan, including those with certain types of dental work or metal implants, as these interfere with image collection.

If your child needs an MRI, doctors will discuss with you any precautions that need to be taken.

How are MRIs used in Angelman syndrome?

Doctors most commonly use MRIs to eliminate other conditions that might be similar to Angelman syndrome. However, recent studies have indicated there are brain features shared by Angelman syndrome patients, which doctors may use to identify these patients. Doctors can also use these brain features to track disease progression.

An MRI allows the doctor to see the tissues of the brain — the  white and gray brain matter. In Angelman syndrome patients, the white matter may be reduced. It is also sometimes possible to see decreased myelination. Myelin is the coating surrounding nerve fibers that protects them from damage and helps the conduction of nerve signals between nerve cells. Without this coating, nerve cells are fragile and easily damaged.

As the disease progresses, the brain abnormalities that doctors may use to diagnose Angelman syndrome can become more severe. Irregularities in blood vessels can become more obvious, and lesions (areas of abnormal tissue) can become apparent.

Researchers don’t understand the causes of these changes well. The studies that have shown the uses of MRI in diagnosing and tracking disease progression have been small. Larger studies are necessary to make MRI imaging a part of the clinical diagnosis and tracking of Angelman syndrome patients.

A current study at the University of North Carolina School of Medicine is recruiting Angelman syndrome patients under age 5.

 

Last updated: Aug. 17, 2020

***

Angelman Syndrome News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Emily holds a Ph.D. in Biochemistry from the University of Iowa and is currently a postdoctoral scholar at the University of Wisconsin-Madison. She graduated with a Masters in Chemistry from the Georgia Institute of Technology and holds a Bachelors in Biology and Chemistry from the University of Central Arkansas. Emily is passionate about science communication, and, in her free time, writes and illustrates children’s stories.
Total Posts: 0
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
×
Emily holds a Ph.D. in Biochemistry from the University of Iowa and is currently a postdoctoral scholar at the University of Wisconsin-Madison. She graduated with a Masters in Chemistry from the Georgia Institute of Technology and holds a Bachelors in Biology and Chemistry from the University of Central Arkansas. Emily is passionate about science communication, and, in her free time, writes and illustrates children’s stories.
Latest Posts
  • genetic test
  • MRI for Angelman syndrome
  • shRNA Gene Therapy

How useful was this post?

Click on a star to rate it!

Average rating 5 / 5. Vote count: 2

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?